Squamous Cell Carcinoma — Trials

Squamous Cell Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

2,930 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 976
Recruiting: 519
Ph III recruiting: 60
Growth YoY: +44.4%
Industry share: 23%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (402)

clinicaltrialsPublishedShowing 201–250 of 467 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05246228	Immune System Modulation and Outcome in High-risk cSCC Treated With Surgery and Radiotherapy(HR-cSCC)	unknown	—	42	Azienda Socio Sanitaria Territoriale degli Spedali Civili di BresciaOTHER	0	Feb 18, 2022	clinicaltrials
NCT03221400	PEN-866 in Patients With Advanced Solid Malignancies	unknown	Phase 1 / Phase 2	340	Tarveda TherapeuticsINDUSTRY	1	Feb 17, 2022